Search
for
Sort by
Research 691–720 of 1000+
- Interleukin-10-deficient Mice Are Less Susceptible to the Induction of Alopecia Areata
- Drug-induced alopecia after dupilumab therapy
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- Autoimmunity: Alopecia Areata
- Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Interdisciplinarity traditional Chinese medicine microneedles in skin disease treatment: Recent advances and challenges
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Tracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
- CAQ Corner: Basic concepts of transplant immunology
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Vitamin D deficiency in patients with alopecia areata: A systematic review and meta-analysis
- Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
- Decreased CD19+CD24hiCD38hi Regulatory B Cells in Alopecia Areata
- Biomarkers in alopecia Areata: A systematic review and meta-analysis.
- Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia Areata: An Update on Treatment Options for Children
- Novel potential therapeutic targets of alopecia areata
- Alopecia Areata: An Updated Review for 2023
- Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata
- The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
- The Role of T‐Helper 17 Cells and Regulatory T Cells in Acute Diffuse and Total Alopecia: The Increased Function of Regulatory T Cells May Explain the Favorable Prognosis
- Case Report: Dupilumab induced sustained complete remission in a child with severe alopecia areata and markedly elevated IgE
- Mite Burden and Immunophenotypic Response to <i>Demodex musculi</i> in Swiss Webster, BALB/c, C57BL/6, and NSG Mice
- Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin
- Vaccines, adjuvants and autoimmunity
- Vitiligo and alopecia areata: apples and oranges?
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention